• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » viihealth acquires decision analytics company Hubdata

viihealth acquires decision analytics company Hubdata

February 21, 2017
CenterWatch Staff

viihealth, a next-generation customer engagement company dedicated to helping global life science clients improve business results, has acquired Hubdata, a French-based provider of decision analytics SaaS solutions.

The Hubdata team has effectively utilized machine learning based advanced analytics to drive business outcomes, such as customer loyalty, yield management, repeat revenue and profitability for international clients. The Hubdata platform provides viihealth the foundational core to effectively add advanced data analytics that provide prediction and prescription guidance in its solution suite to address the needs of life science marketers.

In an increasingly complex digital environment, life science companies are facing critical gaps in executing their digital marketing strategy and need integrated solutions to enhance the value of their customer interactions. This acquisition brings to viihealth new capabilities and expertise to enhance value for clients. Through Hubdata, viihealth will enable life science clients to harness the value of customer interaction data and predictive analytics to deliver operational recommendations. These recommendations guide targeted updates to digital content, improving the value of each customer interaction.

"As a global leader in customer engagement, we equip life science companies with state-of-the-art digital content solutions combined with advanced business intelligence capabilities to drive commercial success across all channels," said Mark Benthin, viihealth founder and executive chairman. "This acquisition demonstrates our ongoing quest to create differentiating add-on value for our clients through smart, targeted and scalable solutions that eliminate pain points and drive commercial benefit," said Sunny Verma, viihealth founder and president.

"We are proud to join the viihealth group in order to enable clients to fully leverage the power of data in their multichannel marketing strategy," said Laurent Cohen, general manager and founder of Hubdata.

The Hubdata acquisition complements the recent commercial release, by viihealth, MCM Builder, a cloud tool for CLM content authoring, which works seamlessly with leading Veeva iRep and other CLM ecosystems to quickly and cost-effectively build and update multi-channel digital content "on the fly"—without the need for cumbersome, costly manual programming.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing